Diversity-oriented synthesis of cembranoid derivatives as potential anti-inflammatory agents. 2021

Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China; Nano Science and Technology Institute, University of Science and Technology of China, 166 Ren Ai Road, Suzhou 215123, China.

Eleven novel cembranoid derivatives were designed, synthesized, and evaluated for their inflammation related activities on the basis of our isolated and previously reported anti-inflammatory marine cembranoids. In bioassay, compound 11 displayed the most promising inhibitory effects with IC50 value of 1.1 μM for the TNF-α inhibitory activity. The further mechanism study of 11 on the inflammatory signaling transduction of RAW264.7 cells was also performed. This research may give an insight for the discovery of marine cembranoid derived anti-inflammatory drug leads.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
March 1982, Il Farmaco; edizione scientifica,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
February 2005, The Journal of pharmacy and pharmacology,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
January 2009, Acta poloniae pharmaceutica,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
March 2022, Molecules (Basel, Switzerland),
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
February 2018, European journal of medicinal chemistry,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
January 2017, Iranian journal of pharmaceutical research : IJPR,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
August 1965, The Journal of pharmacy and pharmacology,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
May 2024, Chemistry & biodiversity,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
July 2010, European journal of medicinal chemistry,
Cong Zhang, and Heng Li, and Jin Liu, and Moting Liu, and Hao Zhang, and Kai-Xian Chen, and Yue-Wei Guo, and Wei Tang, and Xu-Wen Li
April 2021, RSC medicinal chemistry,
Copied contents to your clipboard!